<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nicolas Dauby</style></author><author><style face="normal" font="default" size="100%">Joris Hautekiet</style></author><author><style face="normal" font="default" size="100%">Lucy Catteau</style></author><author><style face="normal" font="default" size="100%">Marion Montourcy</style></author><author><style face="normal" font="default" size="100%">Dominique Van Beckhoven</style></author><author><style face="normal" font="default" size="100%">Bottieau, Emmanuel</style></author><author><style face="normal" font="default" size="100%">Goetghebeur, Els</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Reply to &quot;The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'&quot;.</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Antimicrob Agents</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Hydroxychloroquine</style></keyword><keyword><style  face="normal" font="default" size="100%">Patient Care Planning</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2021 04</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">57</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">4</style></issue></record></records></xml>